Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 9Sarcoma 4Head & Neck 4CNS 4Other hematologic neoplasm 2Other solid neoplasm 1Gastrointestinal 1

Conditions

Glioblastoma 3Cytomegalovirus Infections 1Brain Neoplasms 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Valganciclovir × CNS × Clear all
NCT07383649 2026-04-08

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

The Methodist Hospital Research Institute

Phase 2 Recruiting
28 enrolled
CNS

Brain Neoplasms

NCT04116411 2025-12-22

VIGAS2

Karolinska Institutet

Phase 2 Active not recruiting
220 enrolled
CNS

Glioblastoma

NCT06102525 2025-09-05

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Rznomics, Inc.

Phase 1/2 Recruiting
43 enrolled
CNS

Glioblastoma

NCT00400322 2021-03-01

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Karolinska Institutet

Phase NA Completed
42 enrolled
CNS

Cytomegalovirus Infections, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡